Reprint
State of the Art in Idiopathic Pulmonary Fibrosis
Edited by
January 2023
220 pages
- ISBN978-3-0365-6385-5 (Hardback)
- ISBN978-3-0365-6384-8 (PDF)
This book is a reprint of the Special Issue State of the Art in Idiopathic Pulmonary Fibrosis that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
This reprint is a compilation of ten publications, including original-research and review articles, and the accompanying editorial within the scope of a Special Issue entitled: "State of the Art in Idiopathic Pulmonary Fibrosis" published in Cells.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
interstitial fibrosis; lung; alveolar fibroelastosis; idiopathic pulmonary fibrosis; pirfenidone; nintedanib; discontinuation; body mass index; adverse event; antifibrotic treatment; IPF; alveolar epithelial cells; intermediate epithelial cells; transitional states; LysoTracker; flow cytometry; lung transcriptomic profile; CK5; NGFR; CD24; epidermal growth factor; epidermal growth factor receptor; ErbB-signaling; pulmonary fibrosis; idiopathic pulmonary fibrosis; lung fibrosis; tyrosine kinase inhibitor; TGF-α; TGF-β; amphiregulin; neuregulin 1; basal cells; bronchial epithelium; airway epithelium; lung fibrosis; MUC5B; single cell RNA sequencing; epithelial populations; IPF; antibody folding; immunophilin; lung fibrosis; interstitial lung disease; ER stress; tacrolimus; FK506-binding protein; peptidyl-prolyl isomerase; 3D cultures; IPF modelling; drug screening; idiopathic pulmonary fibrosis (IPF); histone deacetylase (HDAC); histone acetylation; non-histone protein acetylation; fibroblast-to-myofibroblast differentiation (FMD); type-II alveolar epithelial cell (AECII); bronchiolar basal cells; bronchiolization; Class I-HDAC-inhibitor; (pan-)HDAC-inhibitor; IGF1; IGF1R; lung development; bleomycin-induced pulmonary fibrosis; idiopathic pulmonary fibrosis; pulmonary fibrosis; bleomycin; recombinant FGF10; alveolar epithelial progenitors; AT2 cells; n/a